Hepatitis D
- Home
- Viral Hepatitis
- Hepatitis D
Overview
Hepatitis D (also known as Delta Hepatitis) is a viral infection caused by the hepatitis D virus (HDV). It is a unique form of hepatitis because it can only occur in individuals who are already infected with hepatitis B. HDV relies on the hepatitis B virus (HBV) for replication, and as a result, Hepatitis D cannot exist on its own. This co-infection can lead to more severe liver disease, including a higher risk of cirrhosis (scarring of the liver) and liver cancer.
Hepatitis D can either occur as a co-infection with hepatitis B or as a superinfection in individuals who are already chronically infected with hepatitis B.
How is Hepatitis D Spread?
Hepatitis D is transmitted through blood-to-blood contact and shares similar transmission routes with hepatitis B. The primary modes of transmission include:
- Sharing needles or other drug-use equipment
- Receiving contaminated blood or blood products during medical procedures
- Needle stick injuries in healthcare settings
- Sexual contact with an infected individual (though less commonly)
- Mother-to-child transmission during childbirth (although rare)
Since hepatitis D can only infect people already infected with hepatitis B, it is more common in individuals with chronic hepatitis B infection, especially in regions where both infections are prevalent.
What Are the Symptoms of Hepatitis D?
The symptoms of hepatitis D can range from mild to severe and are often similar to those of hepatitis B. When hepatitis D occurs as a superinfection in individuals with chronic hepatitis B, it can worsen liver damage and increase the risk of serious complications.
Common symptoms of hepatitis D include:
- Fatigue
- Loss of appetite
- Abdominal pain (especially in the upper right side)
- Jaundice (yellowing of the skin and eyes)
- Dark urine and pale stools
- Nausea and vomiting
- Fever
If left untreated, chronic hepatitis D can lead to cirrhosis, liver failure, or liver cancer over time.
How is Hepatitis D Diagnosed?
Diagnosis of hepatitis D involves a combination of blood tests and liver function tests to confirm the presence of the hepatitis D virus (HDV) and assess liver damage. The diagnostic process typically includes:
Detects the presence of antibodies to the hepatitis D virus, indicating exposure to the virus.
Confirms active infection by detecting the virus’s genetic material in the blood.
Since HDV can only occur in individuals infected with hepatitis B, this test is used to confirm the presence of the hepatitis B virus.
To measure the extent of liver damage and assess liver enzymes (ALT, AST, bilirubin).
(e.g., ultrasound or elastography) and liver biopsy to evaluate liver damage, fibrosis, or cirrhosis.
Imbalances in sodium, potassium, and other electrolytes may also contribute to HE development.
How is Hepatitis D Treated?
The treatment for hepatitis D is more challenging than for other forms of hepatitis because there is no specific antiviral therapy approved for hepatitis D alone. Treatment usually focuses on managing hepatitis B and hepatitis D together. Common approaches include:
- Interferon therapy: Pegylated interferon (pegIFN) is the main treatment for hepatitis D, although its effectiveness may vary and it is associated with significant side effects.
- Antiviral treatment for hepatitis B: Since hepatitis D relies on hepatitis B for replication, controlling hepatitis B through antiviral therapy (such as tenofovir or entecavir) can help manage hepatitis D symptoms and slow disease progression.
- Liver transplantation: In cases of advanced liver disease, liver failure, or cirrhosis, liver transplantation may be considered if no other treatment options are effective.
Early diagnosis and treatment of both hepatitis B and hepatitis D are crucial to prevent long-term liver damage.
Who is at Risk for Hepatitis D?
Individuals who are already infected with hepatitis B are at risk for hepatitis D. The following groups are at increased risk for hepatitis D:
- People with chronic hepatitis B (particularly those who have not been vaccinated against hepatitis B)
- Injecting drug users who share needles or other drug equipment
- People who have multiple sexual partners or engage in unprotected sex with someone who is infected with hepatitis B or D
- Healthcare workers or anyone with potential blood exposure
- People living in areas where both hepatitis B and hepatitis D are common, such as parts of Africa, the Middle East, and Asia
What is the Outlook for People with Hepatitis D?
The outlook for individuals with hepatitis D can vary. If hepatitis D is diagnosed and treated early, and hepatitis B is well-controlled, the prognosis can be better. However, if left untreated, hepatitis D can lead to severe liver damage, including cirrhosis, liver failure, and liver cancer. The progression of liver disease is usually faster in people with both hepatitis B and D compared to those with hepatitis B alone.
In cases of advanced liver disease, liver transplantation can significantly improve quality of life and offer a chance of recovery.
How Can Liver Transplantation Portal Help You?
At Liver Transplantation Portal, we connect individuals with hepatitis D to expert hepatologists and liver specialists. Whether you’re managing hepatitis D and hepatitis B co-infection or exploring treatment options, our platform provides the latest resources and access to personalized care.
Why Choose Liver Transplantation Portal?
We are committed to offering compassionate care for individuals affected by complex liver diseases like hepatitis D. With access to leading specialists, antiviral therapies, and liver transplant centers, Liver Transplantation Portal ensures that you receive the best treatment and support for your condition.
Contact us today to learn more about hepatitis D, its management, and how we can assist you in navigating this challenging disease.